Ahead of print
| Videosurgery | 2018-04-19
10.5173/ceju.2018.1655 |
|
Victo and Victo plus - novel alternative for the mangement of postprostatectomy incontinence. Early perioperative and postoperative experience
Peter Weibl, Rudi Hoelzel, Michael Rutkowski, Wilhelm Huebner
Artificial hydraulic urinary sphincters (AUS) are the gold standard for the treatment of male stress urinary incontinence. The satisfaction rate is more than 90% however there is still a significant rate of reoperations. The main problems are a sub cuff atrophy and/or an erosion of the urethra. Key factors are the urethral blood flow on the one hand as well as diabetes, hypogonadism and radiotherapy on the other hand and the preventive factors for atrophy and erosion [1].
|
 VIDEO PUBLICATION |
| Original Basic Research And Clinical Articles | 2018-04-16
10.5173/ceju.2018.1639 |
|
Clinical profile and successful outcomes of conservative and minimally invasive treatment of emphysematous pyelonephritis
Vilvapathy Senguttuvan Karthikeyan, Chikka Moga Siddaiah Manohar, Ashwin Mallya, Ramaiah Keshavamurthy, Anant Janardhan Kamath
Emphysematous pyelonephritis (EPN) is a rare clinical entity, characterized by gas in renal system, due to an acute, fulminant and potentially fatal necrotizing process with varying clinical presentations. It is much more aggressive than uncomplicated pyelonephritis with mortality of 20-40% in contemporary meta-analysis.
|
 FULL TEXT |
| Original Basic Research And Clinical Articles | 2018-04-09
10.5173/ceju.2018.1620 |
|
Single-use flexible and semirigid Pusen ureteroscopes, first clinical evaluation
Esteban Emiliani, Asier Mercadé, Felix Millan, Francisco Sanchez-Martin, Cristian Andres Konstantinidis, Oriol Angerri
The purpose of the present study was to clinically evaluate two new single-use PUSEN ureteroscopes, one semirigid with flexible tip (srURS) and one flexible (fURS).
|
FULL TEXT |
| Original Basic Research And Clinical Articles | 2018-03-28
10.5173/ceju.2018.1519 |
|
Office-based ureteric stent removal is achievable, improves clinical flexibility and quality of care, whilst also keeping surgeons close to their patients
Emma Louise Baston, Sophie Wellum, Zosia Bredow, Guy Storey, Anne Palmer, David van Dellen, Ben R. Grey
Diagnostic pressure on endoscopy suites can result in stent removal not receiving the required priority and unnecessary morbidity for patients. As well as using stents with extraction strings, the introduction of a portable single-use flexible cystoscope for ureteric stent removal (IsirisTM), offered an opportunity to negotiate these issues by relocating stent removal to the office/clinic. This study aimed to determine whether such flexibility reduced stent dwell time with the assumption this would improve patient experience and decrease associated complications.
|
FULL TEXT |
| Original Basic Research And Clinical Articles | 2018-03-28
10.5173/ceju.2018.1605 |
|
Urine miRNA as a potential biomarker for bladder cancer detection – a meta-analysis
Piotr Kutwin, Tomasz Konecki, Edyta Marta Borkowska, Magdalena Traczyk-Borszyńska, Zbigniew Jabłonowski
White Light Cystoscopy (WLC), often supported by urine cytology, is considered the "gold standard" in the diagnosis and follow-up of bladder cancer. In recent years urine miRNA tests have been performed in detection of bladder cancer.
|
FULL TEXT |
| Original Basic Research And Clinical Articles | 2018-03-27
10.5173/ceju.2018.1623 |
|
Italian endourological panorama: results from a national Survey.
Guido Giusti, Silvia Proietti, Bhaskar K. Somani, Amelia Pietropaolo, Giuseppe Saitta, Marco Rosso, Franco Gaboardi
to explore the dissemination of flexible ureteroscopy(fURS), shockwave lithotripsy(SWL) and percutaneous nephrolithotomy(PCNL) in the Italian urological community and to know the real availability of the complex endourological armamentarium all over the country.
|
FULL TEXT |
| Original Basic Research And Clinical Articles | 2018-03-23
10.5173/ceju.2018.1653 |
|
Retrograde intrarenal surgery using the single – use flexible ureteroscope Uscope 3022 (PUSEN TM): evaluation of clinical results
José A. Salvadó, Ruben Olivares, José M. Cabello, Renato Cabello, Sergio Moreno, Jessica Pfeifer, Cristóbal Román, Alfredo Velasco
Reusable endoscopes have some limitations regarding its continued use. To sort out this problems, several disposable devices have appeared on the market. Our objective, is to show our clinical results with a new digital flexible single-use ureteroscope.
|
FULL TEXT |
| Review Paper | 2018-03-16
10.5173/ceju.2018.1583 |
|
Molecular alterations associated with prostate cancer
Herney Andres Garcia Perdomo, James A. Zapata-Copete, Adalberto Sanchez
The information and knowledge about pathways and genetic alterations regarding prostate cancer, including the tools available for its study have been increased nowadays. Additionally, a variety of molecular signaling pathways control cell proliferation nonetheless, this uncompletely understood process is disturbed in cancer cells.
|
FULL TEXT |
|
Scientific integrity also concerns editors and publishers
Recently, there have been many dishonest propositions from scientific publishing houses and publishers. Authors receive offers to publish articles in journals of questionable reputability and often an unfairly created image which portrays a resemblance of a journal with high standards possessing an Impact Factor, generated by Clarivate Analytics (previously Thomson Reuters).
Many trademarks imitating the "original" Impact Factor have appeared. These trademarks entice authors to publish articles in journals which do not appear in the Science Citation Index Expanded database, managed by Clarivate Analytics. These journals of course have their own unique impact factors, but they are not indexed by Clarivate Analytics. Authors publish their articles in these journals only to later find out that they will not be indexed in the Science Citation Index Expanded database. Often, these articles cannot be then withdrawn because after an article is assigned a DOI number, it cannot be published in another journal as this would be considered plagiarism. Subsequently, these journals may demand up to a few thousand dollars from authors in order to withdraw their articles.
Why am I writing about this? I am writing about this because I think that editors and publishers must be honest and present credible offers to authors. In my opinion, impact factors that are not the result of parameters calculated by Clarivate Analytics should not be used, even if they are trademarks. In scientific research, the concept of an "Impact Factor" has existed for too long for it to be used by other institutions, even if it is calculated fairly and called an "unofficial impact factor". This is simply a case of scientific integrity.
The SCOPUS database has come up with a very good solution to this problem by naming their impact factor "CiteScore". This is a fair approach to authors by publishers.
As editors and publishers, we must also have an honest approach to scientific research.
Dear authors, please look out for journals which advertise various new impact factors. Before you submit your articles to a journal, make sure to check first in which database it is indexed.
With kind regards,
Tomasz Drewa
Editor-in-Chief
|
